APA (7th ed.) Citation

Muntau, A., & Gramer, G. (2017). Efficacy, safety and population pharmacokinetics of sapropterin in PKU patients <4 years: Results from the SPARK open-label, multicentre, randomized phase IIIb trial. Orphanet journal of rare diseases, 12, . https://doi.org/10.1186/s13023-017-0600-x

Chicago Style (17th ed.) Citation

Muntau, Ania, and Gwendolyn Gramer. "Efficacy, Safety and Population Pharmacokinetics of Sapropterin in PKU Patients <4 Years: Results from the SPARK Open-label, Multicentre, Randomized Phase IIIb Trial." Orphanet Journal of Rare Diseases 12 (2017). https://doi.org/10.1186/s13023-017-0600-x.

MLA (9th ed.) Citation

Muntau, Ania, and Gwendolyn Gramer. "Efficacy, Safety and Population Pharmacokinetics of Sapropterin in PKU Patients <4 Years: Results from the SPARK Open-label, Multicentre, Randomized Phase IIIb Trial." Orphanet Journal of Rare Diseases, vol. 12, 2017, https://doi.org/10.1186/s13023-017-0600-x.